Biofrontera Cash Conversion Cycle from 2010 to 2024

BFRIW Stock  USD 0.13  0.05  64.77%   
Biofrontera Warrants Cash Conversion Cycle yearly trend continues to be fairly stable with very little volatility. Cash Conversion Cycle will likely drop to 92.33 in 2024. During the period from 2010 to 2024, Biofrontera Warrants Cash Conversion Cycle regression line of quarterly data had mean square error of  2,308 and geometric mean of  161.49. View All Fundamentals
 
Cash Conversion Cycle  
First Reported
2010-12-31
Previous Quarter
97.19015675
Current Value
92.33
Quarterly Volatility
46.33789103
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Biofrontera Warrants financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biofrontera Warrants' main balance sheet or income statement drivers, such as Tax Provision of 33 K, Interest Income of 90.6 K or Depreciation And Amortization of 1.5 M, as well as many indicators such as Price To Sales Ratio of 0.12, Dividend Yield of 0.0 or PTB Ratio of 0.85. Biofrontera financial statements analysis is a perfect complement when working with Biofrontera Warrants Valuation or Volatility modules.
  
Check out the analysis of Biofrontera Warrants Correlation against competitors.
For more information on how to buy Biofrontera Stock please use our How to Invest in Biofrontera Warrants guide.

Latest Biofrontera Warrants' Cash Conversion Cycle Growth Pattern

Below is the plot of the Cash Conversion Cycle of Biofrontera Warrants over the last few years. It is Biofrontera Warrants' Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biofrontera Warrants' overall financial position and show how it may be relating to other accounts over time.
Cash Conversion Cycle10 Years Trend
Very volatile
   Cash Conversion Cycle   
       Timeline  

Biofrontera Cash Conversion Cycle Regression Statistics

Arithmetic Mean167.18
Geometric Mean161.49
Coefficient Of Variation27.72
Mean Deviation25.29
Median162.80
Standard Deviation46.34
Sample Variance2,147
Range196
R-Value(0.05)
Mean Square Error2,308
R-Squared0
Significance0.87
Slope(0.47)
Total Sum of Squares30,061

Biofrontera Cash Conversion Cycle History

2024 92.33
2023 97.19
2022 235.85
2021 166.16
2020 288.22

About Biofrontera Warrants Financial Statements

Biofrontera Warrants investors use historical fundamental indicators, such as Biofrontera Warrants' Cash Conversion Cycle, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biofrontera Warrants. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash Conversion Cycle 97.19  92.33 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biofrontera Stock Analysis

When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.